Published on FierceBiotech (http://www.fiercebiotech.com)

Humira approved for juvenile RA

By admin

Created Feb 22 2008 - 6:59am

The FDA has approved Abbott's Humira as a treatment for juvenile rheumatoid arthritis. This marks the sixth approved indication for Abbott's monoclonal antibody. Release [1]

Abbott Labs
arthritis
FDA
Humira
monoclonal antibody
Rheumatoid Arthritis

Source URL: http://www.fiercebiotech.com/story/spotlight-humira-approved-for-juvenile-ra/2008-02-22

Links:
[1] http://www.fiercebiotech.com/press-releases/abbott-receives-fda-approval-humira-adalimumab-polyarticular-juvenile-idiopathic-arth